#ACID PRO 7 COMPLETO TRIAL#
A two-year clinical trial designed to assess the effect of lipoic acid on loss of mobility and changes in brain volume in patients with progressive multiple sclerosis is ongoing. Lipoic acid was found to slow disease progression when administered to a mouse model of multiple sclerosis. It is important to note that many of the studies examining the efficacy of lipoic acid for the treatment of diabetic neuropathy have been conducted by one German research group and funded by the manufacturer of lipoic acid in Germany. (More information)Īvailable evidence suggests that treatment with intravenous or oral lipoic acid may help reduce symptoms of diabetic peripheral neuropathy. Some evidence from small randomized controlled studies suggests that high-dose lipoic acid may improve measures of glucose utilization in subjects with metabolic disorders. Lipoic acid may also trigger antioxidant defense, enhance cellular glucose uptake, and modulate the activity of various cell-signaling molecules and transcription factors. Lipoic acid is a direct antioxidant, although any increase in radical scavenging activity in vivo is likely transient. Supplementation with lipoic acid transiently increases plasma and cellular concentrations of unbound lipoic acid. Endogenously synthesized lipoic acid is bound to protein and functions as a cofactor for several important mitochondrial multi enzyme complexes.Lipoic acid (often called α-lipoic acid), also known as thioctic acid, is a naturally occurring compound that is also synthesized by humans.
#ACID PRO 7 COMPLETO PROFESSIONAL#
Healthcare Professional Continuing Education.
0 kommentar(er)
